Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mo | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.06.2025 | 352 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 02.06.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.06.2025ISIN NameCA19243C1005 COGNETIVITY... ► Artikel lesen | |
LIPIDOR Aktie jetzt für 0€ handeln | |||||
26.05. | Delisting of Lipidor AB from Nasdaq First North Growth Market | 160 | GlobeNewswire | On May 26, 2025, Lipidor AB was declared bankrupt by the Stockholm District Court.
According to item 8.2.7 of the Nasdaq First North Growth Market Rulebook, the exchange may decide to delist... ► Artikel lesen | |
26.05. | XFRA L7R: AUSSETZUNG/SUSPENSION | 93 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILLIPIDOR AB L7R SE0012558617... ► Artikel lesen | |
26.05. | Suspension of Trading in Lipidor AB at FNSE | 146 | GlobeNewswire | 2025-05-26T06:33:44Z
Suspension
At Trading Venue FNSE
Due to Non Disclosure Of
Inside Information About The Issuer Or Financial Instrument
Ongoing:
True
Comments: Nasdaq Stockholm has, to the extent... ► Artikel lesen | |
25.05. | Lipidor AB: Lipidor applies for bankruptcy | 144 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, 25th May 2025 - Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) announces today that the Company's board has resolved to file for bankruptcy on behalf of the Company. The... ► Artikel lesen | |
24.05. | Lipidor AB: Lipidor announces today negative results from the company's Phase III clinical study of AKP02G2 for psoriasis | 87 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, 24th May 2025 - (Nasdaq First North: LIPI) reports negative results from a Phase III clinical study of the AKP02G2 cutaneous spray for mild to moderate plaque psoriasis. The study... ► Artikel lesen | |
19.05. | Lipidor AB: Lipidor announces database lock in its Phase III clinical study of the psoriasis candidate AKP02G2 | 108 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, 19th May 2025 - Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) announces today that the company's Phase III study of AKP02G2 for the treatment of psoriasis has reached... ► Artikel lesen | |
17.03. | Lipidor AB: Lipidor announces all patients enrolled in ongoing Phase III study | 132 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, 17th March 2025 - Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today announces that all patients in the ongoing Phase III study for the drug candidate AKP02G2 have been... ► Artikel lesen | |
28.02. | Lipidor AB: Lipidor AB (publ) publishes year-end report for 2024 | 190 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, 28th February 2025 - Today, Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) publishes its year-end report for the period January - December 2024. The report is available... ► Artikel lesen | |
21.01. | Lipidor AB: Lipidor announces half of patients enrolled in ongoing Phase III study | 481 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, 21st January 2025 - Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today announces that half of the patients in the ongoing Phase III study for the drug candidate AKP02G2... ► Artikel lesen | |
20.11.24 | Lipidor AB: Lipidor publishes CEO statement for the quarter: "Study results expected by the end of Q1 2025" | 129 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, 20 November 2024 - Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today provides an update on the business from CEO Ola Holmlund, also announcing a company presentation... ► Artikel lesen | |
28.08.24 | Lipidor AB: Lipidor AB (publ) publishes interim report for Q2 2024 | 131 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, 28 August 2024 - Today, Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) publishes its interim report for the period January - June 2024. The report is available on the... ► Artikel lesen | |
27.06.24 | Nasdaq Stockholm AB: New equity right for trading, Lipidor AB TO2 | 1.151 | GlobeNewswire | At the request of Lipidor AB, Lipidor AB equity rights will be traded on First
North Growth Market as from June 28, 2024.
Security name: Lipidor AB TO2
------------------------------
Short... ► Artikel lesen | |
26.06.24 | Nasdaq Stockholm AB: The observation status for Lipidor AB is removed | 318 | GlobeNewswire | On December 19, 2022, the shares in Lipidor AB (the "Company") were given
observation status with reference to material adverse uncertainty in respect of
the issuer's financial position.
On April... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
ORAMED PHARMACEUTICALS | 1,855 | -0,88 % | Oramed Pharmaceuticals Inc.: Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical | Oramed leverages its strategic capital markets expertise to support Alpha Tau's breakthrough cancer therapy technology
Accelerating multiple late-stage cancer therapies... ► Artikel lesen | |
MEDMEN ENTERPRISES | - | - | This Week In Cannabis: The MedMen Saga, Multi-Million-Dollar Financings, Controversies In LatAm And More | ||
OPUS GENETICS | 0,899 | +2,28 % | XFRA R3X1: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILOPUS GENETICS DL-... ► Artikel lesen | |
BOIRON | 22,650 | -0,44 % | Boiron USA: Say Goodnight to Teething Troubles with New Camilia(R) Bedtime | Newtown Square, Pennsylvania--(Newsfile Corp. - June 2, 2025) - Restless nights caused by teething discomforts can be tough on babies and parents alike. Boiron, world leader in homeopathic medicines... ► Artikel lesen | |
VERTICAL AEROSPACE | 4,600 | +6,48 % | Vertical Aerospace Appoints Former MI5 Director General Lord Andrew Parker to Board | Former MI5 Director General and Lord Chamberlain brings extensive experience of working at the highest levels of public service
Appointment follows Vertical's announcement of its hybrid-electric... ► Artikel lesen | |
PACIRA BIOSCIENCES | 23,200 | -0,85 % | Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | BRISBANE, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of... ► Artikel lesen | |
RED LIGHT HOLLAND | 0,018 | -30,23 % | Red Light Holland Corp.: Red Light Holland's FDA-Compliant, DEA-Registered Partner Irvine Labs Granted United States Controlled Substances Import Permit for the Company's Raw Psilocybin Truffles | Red Light Holland is moving forward with the import of 3 kg (3000 grams) of raw psilocybin truffles from the Company's farm in The Netherlands to the United States, via a Controlled Substances Import... ► Artikel lesen | |
INNOCARE PHARMA | 1,280 | +3,23 % | INNOCARE (09969): INSIDE INFORMATION ANNOUNCEMENT - APPROVAL OF MINJUVI (TAFASITAMAB) IN COMBINATION WITH LENALIDOMIDE FOR THE TREATMENT OF ADULT PATIENTS ... | ||
PHIBRO ANIMAL HEALTH | 20,800 | 0,00 % | Dividendenbekanntmachungen (04.06.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADESSO SE DE000A0Z23Q5 - 0,75 EUR AGEAS SA/NV BE0974264930 - 2 EUR AIR LEASE CORPORATION US00912X3026 0,22 USD 0,1934 EUR ANALOG... ► Artikel lesen | |
NOVO NORDISK | 63,96 | +0,13 % | DEUTSCHE BANK RESEARCH stuft NOVO NORDISK auf 'Buy' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Novo Nordisk mit einem Kursziel von 750 dänischen Kronen auf "Buy" belassen. Dies schrieb Emmanuel Papadakis in einem am... ► Artikel lesen | |
GSK | 18,055 | 0,00 % | BERENBERG stuft GSK auf 'Hold' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat GSK nach gutem Lauf bei unverändertem Kursziel von 1600 Pence von "Buy" auf "Hold" abgestuft. Die Kursentwicklung des Pharmakonzerns sei in... ► Artikel lesen | |
BAYER | 26,845 | +1,57 % | Bayer, Vidac Pharma, Evotec - schnappen Sie sich den 866 Milliarden Onkologie Jackpot | Die Onkologie erlebt eine beispiellose Revolution. Mit prognostizierten 866 Mrd. USD Marktvolumen bis 2034 und 11 % Jahreswachstum treiben KI-gestützte Diagnosen, personalisierte Gentherapien und Präzisionsmedizin... ► Artikel lesen | |
ELI LILLY | 669,50 | -0,40 % | Eli Lilly, Tesla & Co: Diese Aktien steigen im Juni (fast) immer | Der Juni steht vor der Tür und damit bieten sich wieder bei einigen Aktien attraktive Trading-Chancen für Anleger. Denn eine ganze Reihe von Titeln hat die statistische Angewohnheit, im sechsten Monat... ► Artikel lesen | |
ASTRAZENECA | 127,15 | -0,59 % | Buy or Goodbye?: Rheinmetall, LVMH, Nike und Astrazeneca - Die Analystenstimmen des Tages | © Foto: Marcus Brandt/dpaRheinmetall, LVMH, Nike und Astrazeneca: So bewerten Top-Analysten die Aktien. Ein Überblick.JPMorgan stuft Rheinmetall auf "Overweight" Die US-Bank JPMorgan hat die Einstufung... ► Artikel lesen | |
ABBOTT LABORATORIES | 116,20 | -0,60 % | Pressmaster DMCC: Veteran-Owned Nate Woodard Acquires Abbotts Uniforms, Continuing Legacy of Excellence in Military and Uniformed Servicewear | Quantico, Virginia--(Newsfile Corp. - June 4, 2025) - Nate Woodard, a veteran-owned small business known for its commitment to craftsmanship and service, is proud to announce the acquisition of Abbott... ► Artikel lesen |